Sangamo Therapeutics

American biotechnology company
Organization business Q7417809
Press Enter · cited answer in seconds

Financials

Self-reported XBRL data from 17 annual filings
Revenue
$39.55M
▼ 31.6% YoY FY2025
Net Income
-$122.93M
▼ 25.5% YoY FY2025
Assets
$59.74M
▼ 41.2% YoY FY2025
EPS (diluted)
$-0.44
▲ 10.2% YoY FY2025
$0.00$48.46M$96.93M$145.39M$193.86M FY2009: $22.19M · NI -$18.59M (-83.8% margin)FY2010: $20.80M · NI -$24.85M (-119.5% margin)FY2011: $10.32M · NI -$35.75M (-346.4% margin)FY2012: $21.66M · NI -$22.26M (-102.8% margin)FY2013: $24.13M · NI -$26.62M (-110.3% margin)FY2014: $45.87M · NI -$26.42M (-57.6% margin)FY2015: $39.54M · NI -$40.70M (-102.9% margin)FY2016: $19.39M · NI -$71.66M (-369.6% margin)FY2017: $36.57M · NI -$54.57M (-149.2% margin)FY2018: $84.45M · NI -$68.33M (-80.9% margin)FY2019: $102.43M · NI -$95.19M (-92.9% margin)FY2020: $118.19M · NI -$121.00M (-102.4% margin)FY2021: $110.70M · NI -$178.29M (-161.1% margin)FY2022: $111.30M · NI -$192.28M (-172.8% margin)FY2023: $176.23M · NI -$257.83M (-146.3% margin)FY2024: $57.80M · NI -$97.94M (-169.4% margin)FY2025: $39.55M · NI -$122.93M (-310.8% margin) '09'11'13'15'17'19'21'23'25
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession 0001628280-26-022029

Sangamo Therapeutics

Summary

Sangamo Therapeutics is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (334 views/month).[2]

Key Facts

  • Sangamo Therapeutics is in the country of United States[3].
  • Sangamo Therapeutics is in the country of US[4].
  • Sangamo Therapeutics's instance of is recorded as business[5].
  • Sangamo Therapeutics's instance of is recorded as public company[6].
  • Sangamo Therapeutics's headquarters location is recorded as Richmond[7].
  • Sangamo Therapeutics's stock exchange is recorded as Nasdaq[8].
  • Sangamo Therapeutics's industry is recorded as biotechnology[9].
  • 1995 marks the founding of Sangamo Therapeutics[10].
  • Sangamo Therapeutics's official website is recorded as http://www.sangamo.com[11].
  • Sangamo Therapeutics's legal form is recorded as Delaware corporation[12].
  • Sangamo Therapeutics's legal form is recorded as XTIQ[13].

Body

Founding

1995 marks the founding of Sangamo Therapeutics[10].

Operations

Sangamo Therapeutics's headquarters location is recorded as Richmond[7].

Industry

Sangamo Therapeutics's industry is recorded as biotechnology[9].

Ownership

Sangamo Therapeutics's stock exchange is recorded as Nasdaq[8].

Why It Matters

Sangamo Therapeutics ranks in the top 4% of business entities by monthly Wikipedia readership (334 views/month).[2] It is known by 5 alternative names across languages and contexts.[14]

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Sangamo Therapeutics. Retrieved September 24, 2026, from https://4ort.xyz/entity/sangamo-therapeutics
MLA “Sangamo Therapeutics.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 Sep. 2026, https://4ort.xyz/entity/sangamo-therapeutics.
BibTeX @misc{4ortxyz_sangamo-therapeutics_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Sangamo Therapeutics}}, year = {2026}, url = {https://4ort.xyz/entity/sangamo-therapeutics}, note = {Accessed: 2026-09-24}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Sangamo Therapeutics — https://4ort.xyz/entity/sangamo-therapeutics (retrieved 2026-09-24)

Canonical URL: https://4ort.xyz/entity/sangamo-therapeutics · Last refreshed: